financetom
Business
financetom
/
Business
/
Apollo Commits $3.75 Billion Investment to RWE Joint Venture
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apollo Commits $3.75 Billion Investment to RWE Joint Venture
Sep 8, 2025 12:48 AM

03:27 AM EDT, 09/08/2025 (MT Newswires) -- Apollo Global Management ( APO ) said Monday funds managed by the company have agreed to commit 3.2 billion euros ($3.75 billion) of equity to a new joint venture with German power producer RWE.

The RWE-controlled joint venture will hold and fund RWE's 25.1% stake in transmission system operator Amprion, Apollo said.

The deal is expected to close in Q4, subject to customary conditions.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KP Tissue Says Kruger Products to Sell $135 Million in Unsecured Notes; Funds Will Be Used to Redeem 6% Notes Due April 2025
KP Tissue Says Kruger Products to Sell $135 Million in Unsecured Notes; Funds Will Be Used to Redeem 6% Notes Due April 2025
Nov 3, 2024
07:34 AM EDT, 10/28/2024 (MT Newswires) -- KP Tissue ( KPTSF ) over the weekend said Kruger Products (KPI) will sell $135 million of 6.625% senior unsecured notes due Nov 1, 2031 via a private placement. KPI will use the proceeds to redeem all of its 6% senior unsecured notes due April 24, 2025 and for general corporate purposes. It...
BRIEF-Swiggy Is Seeking To Sell Shares For As Much As 390 Rupees ($4.64) Each In An IPO That May Raise $1.35 Billion - Bloomberg News
BRIEF-Swiggy Is Seeking To Sell Shares For As Much As 390 Rupees ($4.64) Each In An IPO That May Raise $1.35 Billion - Bloomberg News
Nov 3, 2024
Oct 28 (Reuters) - * SWIGGY IS SEEKING TO SELL SHARES FOR AS MUCH AS 390 RUPEES ($4.64) EACH IN AN IPO THAT MAY RAISE $1.35 BILLION - BLOOMBERG NEWS Source : https://tinyurl.com/wp5hxzhf Further company coverage: ...
Evoke Pharma Says Study Showed Gimoti Reduces Emergency Visits in Diabetic Gastroparesis Patients Using GLP-1; Shares Surge Pre-Bell
Evoke Pharma Says Study Showed Gimoti Reduces Emergency Visits in Diabetic Gastroparesis Patients Using GLP-1; Shares Surge Pre-Bell
Nov 3, 2024
07:59 AM EDT, 10/28/2024 (MT Newswires) -- Evoke Pharma ( EVOK ) said Monday that a study showed that its nasal spray, Gimoti, used to treat patients with diabetic gastroparesis who were concurrently using GLP-1, showed reduced healthcare resource utilization compared with oral Metoclopramide. The study showed that all-cause emergency department visits decreased by 55%, while diabetic gastroparesis-related emergency department...
Top Premarket Decliners
Top Premarket Decliners
Nov 3, 2024
07:58 AM EDT, 10/28/2024 (MT Newswires) -- Upexi ( UPXI ) shares fell 22% pre-bell Monday, paring Friday's rally. Royal Philips (PHG) shares slumped 17% after the company reported lower Q3 sales that trailed analysts' estimates and cut its 2024 comparable sales growth guidance. Staffing 360 Solutions ( STAF ) shares dropped 14%, extending Friday's slide. Price: 6.30, Change: -1.80,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved